CWP
IDXX icon

Clark Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Clark Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.32K Sell
12
-6
-33% -$3.37K ﹤0.01% 278
2026
Q1 		$10.1K Sell
18
-12
-40% -$7.7K 0.01% 245
2025
Q4 		$20.3K Hold
30
– – 0.01% 175
2025
Q3 		$20.3K Hold
30
– – 0.01% 175
2025
Q2 		$16.1K Buy
30
+12
+67% +$5.74K 0.01% 173
2025
Q1 		$7.56K Buy
+18
New +$7.82K 0.01% 222

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Clark Wealth Partners's IDXX Position: Q2 2026 in Review

Clark Wealth Partners reduced its Idexx Laboratories (IDXX) stake by 33% in Q2 2026, selling an estimated $3.37K and leaving 12 shares worth $6.32K. The position accounts for ﹤0.01% of the portfolio, ranked #278.

Clark Wealth Partners first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $20.3K in Q4 2025. 1,231 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Clark Wealth Partners held 12 shares of Idexx Laboratories worth $6.32K as of Q2 2026.
  • Clark Wealth Partners sold 6 Idexx Laboratories shares in Q2 2026, an estimated $3.37K.
  • Idexx Laboratories made up ﹤0.01% of Clark Wealth Partners's portfolio in Q2 2026, its #278 holding.
  • Clark Wealth Partners first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • Clark Wealth Partners's Idexx Laboratories position peaked at $20.3K in Q4 2025.
  • 1,231 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.